LEVOXYL
Levoxyl (levothyroxine sodium tablets, USP)
Approved
Approval ID
ca3059aa-4d4c-4623-8b00-06b95ef0714a
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 6, 2013
Manufacturers
FDA
Dispensing Solutions, Inc.
DUNS: 066070785
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LEVOTHYROXINE SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code66336-601
Application NumberNDA021301
Product Classification
M
Marketing Category
C73594
G
Generic Name
LEVOTHYROXINE SODIUM
Product Specifications
Route of AdministrationORAL
Effective DateNovember 5, 2013
FDA Product Classification
INGREDIENTS (1)
LEVOTHYROXINE SODIUMActive
Quantity: 100 ug in 1 1
Code: 9J765S329G
Classification: ACTIR
LEVOTHYROXINE SODIUM
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code66336-600
Application NumberNDA021301
Product Classification
M
Marketing Category
C73594
G
Generic Name
LEVOTHYROXINE SODIUM
Product Specifications
Route of AdministrationORAL
Effective DateNovember 5, 2013
FDA Product Classification
INGREDIENTS (1)
LEVOTHYROXINE SODIUMActive
Quantity: 50 ug in 1 1
Code: 9J765S329G
Classification: ACTIR